Longitudinal Variations of CDC42 in Patients With Acute Ischemic Stroke During 3-Year Period: Correlation With CD4<sup>+</sup> T Cells, Disease Severity, and Prognosis.

Front Neurol · 2022 · PMC9081787 · PMID 35547377

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

an increasing trendno p-value reported

Specifically, in patients with AIS, CDC42 showed a gradual decrease from admission [0.500 (IQR: 0.320–0.800)] to 3 days [0.375 (IQR: 0.220–0.665)], then it showed an increasing trend from 3 days to 3 years [0.865 (IQR: 0.480–1.178)].

also in 63,971 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.